Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.

What the source reports

12 new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended 12 medicines for approval at its September 2026 meeting.The committee recommended…, CHMP statistics Key figures from the September 2026 CHMP meeting are represented in the graphic below.

© European Medicines Agency, CHMP statistics:…, Positive recommendations on new medicines, Frehemgo International non-proprietary name (INN) denecimig Marketing authorisation applicant Novo Nordisk A/S Therapeutic indication Treatment of prophylaxis…, Gevalka INN ensartinib Marketing authorisation applicant SFL Pharmaceuticals Deutschland GmbH Therapeutic indication The treatment of adult patients with…,…

Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.

Source & verification

Primary source: News and press releases · September 18, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.